
ã«ããæ¿åºãCOVIDã¯ã¯ãã³ã¡ãŒã«ãŒãšã®ååŒã§1å5000äžãã«ã®æå€±ãåºããã®ã£ã³ãã«ãèªãã
å èšäºã¯ãã¡ããã/Click here to read the original article.
ã¡ãã£ã«ãŽç€Ÿãšã®å¥çŽã§ã¯ã7,600äžååã®ã³ããæ³šå°ã補é ãããããšã«ãªã£ãŠãããã1ååãçŽå ¥ãããªãã£ãã
ãªã³ã¿ãªãªå·ãªã¿ã¯ïŒLifeSiteNewsïŒ - ã«ããã®å ¬å ±äºæ¥çã¯ãã±ããã¯å·ãæ ç¹ãšããã¡ãã£ã«ãŽç€Ÿãé£éŠæ¿åºã®è³éãå©çšããŠCOVIDãžã£ãå·¥å Žã建èšããèšç»ãå®çŸããªãã£ããããçŽçšè ã®çšéã§1å5000äžãã«ã®æå€±ãåºããšãã倧åæãæã£ãããšãèªããã
æææ¥ãå ¬å ±äºæ¥çã¯ã¡ãã£ã«ãŽç€Ÿã®å·¥å Žã«è£å©éãåºããšãã "ãªã¹ã¯ "ãåã£ããšè¿°ã¹ãã
æææ¥ã«äžé¢ã®ä¿å¥å§å¡äŒã§èšŒèšããå ¬å ±äºæ¥å±å±é·ã®ãžã§ãšã«ã»ãã±ããæ°ã¯ããæã ã¯ãã«ããäººå šå¡ã®ããã«ååãªã¯ã¯ãã³ãæ§ã ãªæ¥è ãšå¥çŽãããšãããªã¹ã¯ãè² ã£ãããšèªããã
ã¡ãã£ã«ãŽç€Ÿã倱æããå¥çŽã§ã¯ãèªç€Ÿã®COVIDãžã£ãã7,600äžåå補é ããããšã«ãªã£ãŠãããããããäžåºŠãé éãããªãã£ããã¡ãã£ã«ãŽç€Ÿã¯æ¥æ¬ã®äžè±ååŠã°ã«ãŒãã®åäŒç€Ÿã§ããã
å æãLifeSiteNewsã¯ãäžé¢ä¿å¥å§å¡äŒãã補è¬äŒç€Ÿãšã®COVIDãžã£ãäºæ¥ã®å€±æã§3åãã«ä»¥äžã®çšéãã©ã®ããã«å€±ããããã«ã€ããŠãåçãæ±ããŠããããšãå ±ããã
æè¿ãã«ããå ¬è¡è¡çå±ïŒPHACïŒã2022å¹Žã«æªå ¬è¡šã®äŒæ¥ãšã®COVIDãžã£ãå¥çŽã§1å5000äžãã«ã倱ã£ãããšãæããã«ãªã£ããããã«ãç¬èªã®æ€ç©ç±æ¥COVID泚å°è¬ã®éçºã«å€±æãã2023幎ã«ééãããšçºè¡šããã¡ãã£ã«ãŽç€Ÿã«äžãããã1å7300äžãã«ã倱ãããŠããã
ã«ããä¿å¥çãæ¿èªããã®ã¯ããã¡ã€ã¶ãŒç€Ÿãã¢ãã瀟ããžã§ã³ãœã³ã»ãšã³ãã»ãžã§ã³ãœã³ç€Ÿã®ãã®ãªã©ãä»åœã§è£œé ãããmRNAããŒã¹ã®COVID泚å°è¬ã®ã¿ã§ããã
9æãã«ããä¿å¥çã¯ã35人ã«1人ãå¿çé害ãèµ·ããããšãã調æ»çµæã«ãããããããä¿®æ£ãããã¢ãã瀟ã®mRNAããŒã¹ã®COVID泚å°ãæ¿èªããã
2021幎ããã¥ã¯ãã¯äžé¢ã§ ãç§ã®éžæåºã«ã¡ãã£ã«ãŽãããç¹æš© ããåŸããšã»ããç¬ãã ã
æææ¥ã®äžé¢ä¿å¥å§å¡äŒã§ãã«ããä¿å®å ïŒCPCïŒã®ãªãã¯ã»ããŒãã³ã¹è°å¡ã¯ããïŒã¡ãã£ã«ãŽæ€ç©ã«é¢ããïŒç¥çæææš©ã¯èª°ã®ãã®ãïŒããšè³ªåããã
ããã«å¯ŸããŠãã±ããã¯ããç¥ç財ç£ã¯ã¡ãã£ã«ãŽãææããŠãã ããšè¿°ã¹ãã
ããŒãã³ãºã¯ãæããã«èª¬æè²¬ä»»ãæãããªããŸãŸã倱æããå¥çŽãé²ããããšãèš±ãããã®ã¯ ããã ãã ä¿¡ããããªã ããšè¿°ã¹ãã
ãã±ããã¯ããã®æ¥è§Šãæ®éã§ã¯ãªãã£ãããšãèªããã
ãã©ã®ã¯ã¯ãã³ãå®éã«èªå¯ããããã¯ããã®æç¹ã§ã¯ããããŸããã§ããããšãã±ããã¯èšããããããã®å¥çŽãçµãã æç¹ã§ã¯ãååšããã¯ã¯ãã³ã¯ãããŸããã§ãããç§ãã¡ã¯ãªã¹ã¯ãåããã®ã§ãã
åããå ¬å ±äºæ¥å±ã®ã¢ã³ãã¬ã¢ã»ã¢ã³ãã©ãã£ãã¯å±é·ã«ããã°ã1å5000äžãã«ã¯2020幎ã®äºåè³Œå ¥å¥çŽã«åºã¥ããŠã¡ãã£ã«ãŽç€Ÿã«æ¯æããããã®ã ãšãããããããã¡ãã£ã«ãŽç€Ÿãæšå¹Ž2æã«å·¥å Žééãçºè¡šããåŸããã®å¥çŽã¯ç¡å¹ã«ãªã£ãã
ã¢ã³ãã©ãã£ãã¯ã¯ããã¡ãã£ã«ãŽã¯è£œåã®åé¡ãçŽæã®åé¡ã«ãçŽé¢ããŠããããšãããå¥çŽãèŠçŽããããã®è©±ãåããé²ããããŠãããšè¿°ã¹ãã
ã芪äŒç€Ÿã®äžè±ã¯åç±³ã§ã®æŽ»åãäžæ¢ãããšçºè¡šãããã
ããããæ¯æãæ¡ä»¶ã®äžéšãšããŠãã1å5000äžãã«ïŒè¿éäžå¯ïŒã®åæãé ããããåæãå¥çŽã«åŸã£ãŠãæ¥æ¬ã®ã¡ãã£ã«ãŽç€Ÿã«æ¯æãããããšã¢ã³ãã©ãã£ãã¯ã¯ä»ãå ããã
ãã¡ãã£ã«ãŽç€Ÿã¯æ¯æãæ¡ä»¶ããã¹ãŠæºãããŠããŸããããšã¢ã³ãã©ãã£ãã¯ã¯ä»ãå ããã
ããããåœäŒè°å¡ã¯äºåè³Œå ¥å¥çŽã®æ¡ä»¶ã¯ç§å¯ã§ãããšèšãããããã®ãããã±ããã¯ãããã¯ã®ãžã¥ãªãŒã»ãŽã£ãã§ã©è°å¡ã¯ãããã®æ¡ä»¶ã«ã€ããŠæããŠãã ãã ããšè³ªåããã
ããã«å¯ŸããŠã¢ã³ãã©ãã£ãã¯ã¯ãåœæã¯ ãå€ãã®ãªã¹ã¯ããã£ãããšäž»åŒµãããããããèšããŸããããšçããã
ãã©ã®ã¯ã¯ãã³ãã«ããä¿å¥çã®èªå¯ãåŸãããã®ããä»®ã«èªå¯ããããšããŠããã€å ¥æã§ããã®ããç§ãã¡ã«ã¯ããããŸããã§ããããšã¢ã³ãã©ãã£ãã¯ã¯äž»åŒµããã
ãžã£ã¹ãã£ã³ã»ãã«ããŒéŠçžæ¿æš©ã¯ã¯ã¯ãã³ã«80åãã«ïŒçŽ8000ååïŒãè²»ããããã®å€§éšåããã¡ã€ã¶ãŒç€Ÿãç¬å ããŠãããã«ããä¿å¥çã¯2å3800äžæ¬ã®COVID泚å°ããã¡ã€ã¶ãŒã«ããã«çºæ³šããŠããããã®äžã«ã¯2023幎ãš2024幎çšã®3000äžæ¬ãå«ãŸããŠããã
LifeSiteNewsã¯æè¿ãã«ããé£éŠæ¿åºãšãã¡ã€ã¶ãŒç€Ÿãšã®COVID-19ã¯ã¯ãã³å¥çŽã®è©³çްã«ã€ããŠå ±ããã
ãã¡ã€ã¶ãŒç€Ÿãšã®å¥çŽã¯ãé·æçãªå®å šæ§ãšæå¹æ§ãæªç¥æ°ã§ããããšãæ¿åºãåãå ¥ããããšã«åæããããšã瀺ããŠããããã¡ã€ã¶ãŒç€Ÿãšã®å¥çŽã®è©³çްã«ã¯ãæ¿åºãäºé²æ³šå°ã«è²»ãããéé¡ã¯æããã«ãããŠããªãã
ãã«ããŒæ¿åºã¯ãŸããã¢ã¹ãã©ãŒãã«ããžã§ã³ãœã³ã»ãšã³ãã»ãžã§ã³ãœã³ãã¡ãã£ã«ãŽãã¢ãããããããã¯ã¹ããµããã£ãšãCOVID-19å¥çŽãçµãã§ãããæ¥çã®ã¬ãŒãã«ãããšãç±³åœã«è²©å£²ãããéã®æ³šå°ã®å¹³åäŸ¡æ Œã¯19.50ãã«ã ã£ãã
ãã«ããŒæ¿æš©ã¯å·æ¿åºã®ååãåŸãŠCOVIDãžã£ããåœæ°ã«æŒãä»ãã
COVID泚å°ã¯ããã«ããŒæ¿åºãå šå·æ¿åºã®ååãåŸãŠå€§ã çã«å®£äŒãããããããCOVIDãã³ãããã¯ã®éããã«ããŒã¯å®éšçãªCOVIDäºé²æ¥çš®ãåããªãããšãéžæãã人ã ãæããã人ã ã ãšåŒãã ã
2021幎ããã«ããŒã¯ãã¯ã¯ãã³æ¥çš®ã«çå察ãããã«ãã人ã¯ãç§åŠãä¿¡ããŠãããããããã°ãã°å¥³æ§å·®å¥äž»çŸ©è ã§ããããããã°ãã°äººçš®å·®å¥äž»çŸ©è ã§ããããšè¿°ã¹ãã«ããã¯ãã®ãããªäººã ãã容èªããç¶ããã¹ããã©ããçåãåããã
4æã«ã¯ãCOVID-19ã®æ¥çš®ã "åŒ·å¶ "ããŠããªããšäž»åŒµããéé£ã济ã³ãã
mRNAã䜿ã£ãCOVID泚å°ã«ã¯ãåäŸãå«ããŠéåžžã«å€§ããªãªã¹ã¯ãããããšã蚌æããã€ã€ããã
ã«ãããæ ç¹ãšããCorrelation Research in the Public Interestã®ç ç©¶è ãè¡ã£ãæè¿ã®ç ç©¶ã§ã¯ã17ã«åœã§å šæ»å æ»äº¡çã®ããŒã¯ãšCOVID泚å°ãããŒã¹ã¿ãŒã®æ¥éãªæ®åãšã®éã«ãæç¢ºãªå æé¢ä¿ããããããšã倿ããã
LifeSiteNewsã¯å æãããªãªã¯ã¯ãã³ã«äœ¿ãããŠããããªãªãŠã€ã«ã¹SV40ãããã¡ã€ã¶ãŒç€Ÿã®COVID泚å°ã«å«ãŸããŠããããšãã«ããä¿å¥çã«ãã£ãŠç¢ºèªãããããšå ±ããã
ã«ããã®ä¿å®å ã¯ãCOVID屿©ã®åæã«ã¯æ²é»ãå®ã£ãŠããããåŸã«COVIDã®çŸ©ååã«å察ããããšã衚æããã
åå å éŠã®ããšãŒã«ã»ãã¯ãªãšãŒãŽã«ãæè¿æåºããæ³æ¡ã¯ãå°æ¥ã®æ¥çš®çŸ©ååãçŠæ¢ããããšã§ã«ãã人ã«ã身äœã®èªåŸæ§ããåãæ»ããããšãããã®ã ã£ããããã«ããŒèªç±å ãªã©ããããæåŠãããããåŠæ±ºãããã
COVIDã®ååæ¥çš®ã«ããå¯äœçšã®ãããé£éŠã¯ã¯ãã³å·å®³ããã°ã©ã ïŒVISPïŒãéããŠãæ¥çš®ã«ããå·å®³ã®ééçè£åãç³è«ããã«ãã人ãå¢ããŠããã
VISPã¯ãã§ã«COVID泚å°ã§è² å·ãã人ã ã«600äžãã«ä»¥äžãæ¯æã£ãŠããã2,000ä»¶ã®è«æ±ãæ®ã£ãŠããã